Why is the Bubs (ASX:BUB) share price leaping 7% on Tuesday?

Let's further analyse.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bubs Australia Ltd (ASX: BUB) share price is set to finish today's session strongly in the green.

Investors have bid shares in the goat milk infant formula company 7% higher.

By comparison, the broader S&P/ASX200 Index (ASX: XJO) has sunk more than 1.4% today.

So what's been fuelling the Bubs share price?

Two young girls drinking milkshakes with milk around their mouths.

Image source: Getty Images

What's pushing the Bubs share price today?

Bubs has not released any price-sensitive news that could explain today's bullish price action.

As a result, there are a few factors that could be pushing shares in the infant formula company higher.

Firstly, shares in fellow infant formula producer A2 Milk Company Ltd (ASX: A2M) have enjoyed a strong run recently.

As a result, sentiment towards the sector could be parlayed onto the Bubs share price.

Secondly, investors might have had a change in heart towards Bub's recent news of expanding into the US.

Earlier this month the company announced plans to expand into the lucrative North American market.

The company's formula products will be launched on both Walmart Inc's (NYSE: WMT) and Amazon.com, Inc.'s (NASDAQ: AMZN) online stores.

Investors did not react to the news favourably, with the Bub share price sinking more than 9% on the day.

The company had flagged first shipment of products in its results presentation for FY21.  

How did Bub's perform in FY21?

Late last month, shares in Bubs took a tumble following a disappointing full-year report.

The infant formula company posted a huge loss for FY21, with a 24% decline in revenue of $46.8 million.

The dour result was driven by a 44% decline in Australian sales to $20.4 million and a 17.5% decline in China sales to $10.47 million.

Other highlights from the company's full-year report included;

  • Underlying EBITDA loss of $28.5 million
  • Statutory loss after tax of $74.7 million
  • Cash balance of $27.9 million

Part of the company's loss for the full year was attributed to a $44.6 million non-cash impairment relating to the Nulac Foods cash generating unit.

Bubs noted that weaker sales, a $12.6 million inventory write down, and the sale of excess bulk powder attributed to a bloated operating loss.

Snapshot of the Bubs share price

Today has provided a brief reprieve for Bub's shareholders.

Shares in the infant formula company have not had a great year, trading more than 39% lower since the start of 2021.

At the time of writing, the Bubs share price is poised to close today's session more than 5% higher.

The company's shares were up more than 11% earlier, having hit an intra-day high of 38 cents.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Motley Fool contributor Nikhil Gangaram owns shares of A2 Milk. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Amazon. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended the following options: long January 2022 $1,920 calls on Amazon and short January 2022 $1,940 calls on Amazon. The Motley Fool Australia has recommended A2 Milk, Amazon, and BUBS AUST FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »